IBM Made $10M Investment in MDS Proteomics, MDS Says | GenomeWeb

NEW YORK, March 8 – IBM’s investment in MDS Proteomics totaled $10 million, parent company MDS of Toronto disclosed Thursday.

In January, IBM made an equity investment in MDS Proteomics as part of a strategic collaboration that also included an agreement to jointly establish a publicly available web-based protein database. At the time of the deal neither party disclosed the size of the investment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.